Potassium and Hyperparathyroidism secondary - a phase IV clinical study of FDA data

Summary:

Hyperparathyroidism secondary is reported as a side effect among people who take Potassium (potassium), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Nexium, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Hyperparathyroidism secondary when taking Potassium. It is created by eHealthMe based on reports of 58,337 people who have side effects when taking Potassium from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.

What is Hyperparathyroidism secondary?

Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary) is found to be associated with 698 drugs and 462 conditions by eHealthMe. Check the latest studies of Hyperparathyroidism secondary.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

58,337 people reported to have side effects when taking Potassium.
Among them, 64 people (0.11%) have Hyperparathyroidism secondary.

Could Potassium cause Hyperparathyroidism secondary?

Among these 64 people:

How long have people been on Potassium when they have Hyperparathyroidism secondary? *

What is the gender of people who have Hyperparathyroidism secondary when taking Potassium? *

female: 64.06 %
male: 35.94 %

What is the age of people who have Hyperparathyroidism secondary when taking Potassium? *

What are other drugs people take besides Potassium? *

What are other side effects people have besides Hyperparathyroidism secondary? *

Chronic Kidney Disease: 53 people, 82.81%
Acute Kidney Failure: 46 people, 71.88%
Nephrogenic Anaemia (anaemia due to kidney disease): 28 people, 43.75%
Interstitial Nephritis (inflammation of the kidney): 12 people, 18.75%
Renal Tubular Necrosis (death of kidney tubules): 11 people, 17.19%
Diarrhea: 9 people, 14.06%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 9 people, 14.06%
Pain In Jaw: 9 people, 14.06%
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 7 people, 10.94%
Osteomalacia (softening of the bones due to a lack of vitamin d): 7 people, 10.94%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 48 people, 75.00%
Pain: 26 people, 40.62%
High Blood Cholesterol: 19 people, 29.69%
Infection: 18 people, 28.12%
Gout (uric acid crystals building up in the body): 10 people, 15.62%
Blood Pressure Abnormal: 8 people, 12.50%
Cardiac Disorder: 8 people, 12.50%
Diabetes: 8 people, 12.50%
Hypersensitivity: 7 people, 10.94%
Osteoporosis (bones weak and more likely to break): 7 people, 10.94%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and have Hyperparathyroidism secondary?

- Check whether Hyperparathyroidism secondary is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Potassium:

Potassium (59,147 reports)

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperparathyroidism secondary:

Hyperparathyroidism secondary (698 drugs)

Browse all the conditions that are associated with Hyperparathyroidism secondary:

Hyperparathyroidism secondary (462 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium (the active ingredients of Potassium) and Potassium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.